Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

FRA/TD5A stock hub

FRA/TD5A has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/TD5Ais not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

901.3M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/TD5AFRA/TD5A

—

Loading chart…

In the news

Latest news · FRA/TD5A

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-65.7

P25 n/aP50 n/aP75 n/a

ROIC-20.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/TD5A market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

USD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	2,500
Employees Change	250%
Employees Change Percent	10.42
Enterprise value	EUR 1B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Electromedical and Electrotherapeutic Apparatus
Last refreshed	2026-05-10
Market cap	EUR 901.3M
Price	EUR 13.8
Price currency	EUR
Rev Per Employee	356,472.44x
Sic	3845
Symbol	fra/TD5A
Website	https://www.tandemdiabetes.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.1%
EV Earnings	-12.7x
EV/FCF	-329.75x
EV/Sales	1.19x
FCF yield	-0.35%
P/B ratio	7.85x
P/S ratio	1.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.94%
EBITDA Margin	-4.2%
Gross margin	54.93%
Gross Profit	EUR 489.5M
Gross Profit Growth	9.95%
Gross Profit Growth Q	15.52%
Gross Profit Growth3 Y	11.72%
Gross Profit Growth5 Y	14.76%
Net Income	EUR -82M
Pretax Margin	-9.54%
Profit Margin	-9.2%
Profit Per Employee	EUR -32,800
ROA	-3.68
Roa5y	-4.54
ROCE	-6.74
ROE	-65.73
Roe5y	-41.61
ROIC	-20.06
Roic5y	-25.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-14.52%
Cagr1y	-26.1%
Cagr3y	-25.88%
Cagr5y	-27.99%
OCF Growth	40.65%
OCF Growth3 Y	2.26%
OCF Growth5 Y	-23.32%
Revenue Growth	4.54x
Revenue Growth Q	5.46x
Revenue Growth3 Y	8.94x
Revenue Growth5 Y	13.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.99
Assets	EUR 1B
Cash	EUR 494.6M
Current Assets	EUR 752.2M
Current Liabilities	EUR 210.3M
Debt	EUR 637.2M
Debt Equity	EUR 5.55
Debt FCF	EUR -202
Equity	EUR 114.8M
Interest Coverage	-7.4
Liabilities	EUR 885.5M
Long Term Assets	EUR 248.1M
Long Term Liabilities	EUR 675.2M
Net Cash	EUR -142.7M
Net Cash By Market Cap	EUR -15.83
Net Debt Equity	EUR 1.24
Tangible Book Value	EUR 114.8M
Tangible Book Value Per Share	EUR 1.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.58
Inventory Turnover	3.46
Net Working Capital	EUR 77.2M
Quick ratio	2.87
Working Capital	EUR 554.3M
Working Capital Turnover	EUR 1.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-79.16%
1Y total return	-26.08%
200-day SMA	15.31
3Y total return	-59.29%
50-day SMA	18.33
50-day SMA vs 200-day SMA	50over200
5Y total return	-80.63%
All Time High	136.5
All Time High Change	-89.89%
All Time High Date	2021-12-29
All Time Low	1.88
All Time Low Change	634.04%
All Time Low Date	2018-02-12
ATR	0.81
Ch YTD	-26.71
High	17.4
High52	23.09
High52 Date	2026-02-25
High52ch	-40.23%
Low	13.8
Low52	8.79
Low52 Date	2025-08-11
Low52ch	57.03%
Ma50ch	-24.71%
Price vs 200-day SMA	-9.88%
RSI	31.99
RSI Monthly	41.53
RSI Weekly	41.78
Sharpe ratio	-0.21x
Sortino ratio	-0.22
Total Return	-3.14%
Tr YTD	-26.71
Tr1m	-16.36%
Tr1w	-16.36%
Tr3m	-13.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -53M
Operating margin	-5.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,785,161%
Net Borrowing	219,825,668.9
Shares Insiders	1.05%
Shares Institutions	107.78%
Shares Qo Q	0.56%
Shares Yo Y	3.14%
Short Ratio	4.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -74.8M
Average Volume	110.65x
Bv Per Share	1.68
CAPEX	EUR -20.2M
Ch10y	-79.16
Ch1m	-16.36
Ch1w	-16.36
Ch1y	-26.08
Ch3m	-13.4
Ch3y	-59.29
Ch5y	-80.63
Ch6m	1.43
Change	-9.8%
Change From Open	-20.69
Close	15.3
Days Gap	13.73
Depreciation Amortization	15,143,753.4
Dollar Volume	12,972
Earnings Date	2026-05-07
EBIT	EUR -53M
EBITDA	EUR -37.5M
EPS	EUR -1.21
F Score	4
FCF	EUR -3.2M
FCF EV Yield	-0.3x
Financing CF	204,233,539
Fiscal Year End	December
Founded	2,006
Income Tax	EUR -3M
Investing CF	-114,273,713
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2017-10-10
Last Split Type	Reverse
Ma150	16.78
Ma150ch	-17.76%
Ma20	16.7
Ma20ch	-17.34%
Net CF	109,063,842
Open	17.4
P OCF Ratio	52.99
Position In Range	0
Ppne	151,776,718.4
Price Date	2026-05-08
Ptbv Ratio	7.85
Relative Volume	8.5x
Revenue	891,181,106x
SBC By Revenue	8.03x
Share Based Comp	71,597,350
Tax By Revenue	-0.34x
Tr6m	1.43%
Volume	940
Z Score	0.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/TD5A pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/TD5A stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/TD5A?

Insider, institutional, and short-interest positioning.

Institutional ownership

+107.8%

Share of float held by funds and institutions

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/TD5A momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.0

Neutral momentum band

Price vs 200-day MA

-9.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/TD5A

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/TD5A stock rating?

fra/TD5A is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/TD5A analysis?

The full report lives at /stocks/fra/TD5A/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/TD5A?

The latest report frames fra/TD5A around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/TD5A page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.